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Abstract
Although it has been shown that HIF1 and 2 fulfill essential roles within the hematopoietic system and in the regulation of
HSC fate, little is currently known about the specific mechanisms that are involved. We identified transcriptome changes
induced by hypoxia, constitutively active HIF1(P402/564) and HIF2(P405/531) in human cord blood CD34+ cells. Thus, we were
able to identify common hypoxia-HIF1-HIF2 gene signatures, but we also identified specific target genes that were
exclusively regulated by HIF1, HIF2 or hypoxia. Geneset enrichment analysis (GSEA) revealed that, besides known pathways
associated with ‘‘hypoxia-induced signaling’’, also significant enrichment for the Transforming Growth Factor beta (TGFb)
pathway was observed within the hypoxia/HIF1/HIF2 transcriptomes. One of the most significantly upregulated genes in
both gene sets was the cyclin dependent kinase inhibitor CDKN1C (p57kip2). Combined hypoxia treatment or HIF
overexpression together with TGFb stimulation resulted in enhanced expression of CDKN1C and enhanced cell cycle arrest
within the CD34+/CD382 stem cell compartment. Interestingly, we observed that CD34+ cells cultured under hypoxic
conditions secreted high levels of latent TGFb, suggesting an auto- or paracrine role of TGFb in the regulation of quiescence
of these cells. However, knockdown of SMAD4 could not rescue the hypoxia induced cell cycle arrest, arguing against direct
effects of hypoxia-induced secreted TGFb. Finally, the Ga-coupled receptor GTPase RGS1 was identified as a HIF-dependent
hypoxia target that dampens SDF1-induced migration and signal transduction in human CD34+ stem/progenitor cells.
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Introduction
Hematopoietic stem cells (HSCs) reside within specialized
hypoxic niches in the bone marrow microenvironment where
they are kept in a relative quiescent state [21,24,26,27,31,34,41].
One of the key pathways activated under low oxygen conditions is
the Hypoxia-inducible factor (HIF) pathway. HIF1a and HIF2a
(EPAS1) act as oxygen sensors that are degraded under normoxic
conditions but at lower oxygen levels HIF proteins are stabilized,
translocate to the nucleus and initiate gene transcription
[20,28,38]. In well-oxygenated conditions HIFs are bound by
the Von Hippel Lindau (VHL) tumor suppressor protein which
recruits an ubiquitin ligase that targets these transcription factors
for proteasomal degradation [18]. VHL binding is critically
dependent on hydroxylation of proline residues in HIF1 (P405 and
P564) and HIF2 (P405 and P531) [40]. The oxygen-sensitive a
subunits of HIF1 or HIF2 can heterodimerize with the stable
HIF1b (ARNT) subunit that together forms a basic helix-loop-
helix-PAS (bHLH-PAS) transcriptional regulator that binds to the
core sequence RCGTG termed the hypoxia response element
(HRE) in promoters of presumed target genes [18,20,28,38].
Using murine knockout models it has been shown that both
HIF1a and HIF2a fulfill essential and at least in part non-
overlapping roles in hematopoiesis. Conditional depletion of
HIF1a resulted in loss of HSC quiescence and loss of stem cell
function when exposed to stress such as transplantation, myelo-
suppression or upon aging [42]. Stabilization of HIF1a, either by
loss of VHL [42] or by using pharmacological inhibitors that
target prolyl hydroxylases [13], resulted in increased HSC
quiescence and improved hematopoietic recovery after myelosup-
pressive conditions. Historically, the influence of hypoxia on the
behaviour of hematopoietic stem and progenitor cells has been
studied in vitro by culturing murine and human bone marrow cells
under reduced oxygen tension. It was shown that murine bone
marrow generated roughly two-fold more CFU-GM colonies
when this assay was performed under reduced (5%) oxygen
conditions [2,6]. Culturing murine or human bone marrow cells
for a limited period of time under 1% oxygen conditions was
shown to result in a preservation of the progenitor-generating
compartment as compared to normoxic conditions [8,17].
Furthermore, by using a transplantation model, it was shown that
the repopulating activity of HSCs could be maintained or even
expanded when cultured in vitro under reduced oxygen conditions
[9,11]. Furthermore, it was shown that long-term HSCs reside
within the glycolysis-dependent subpopulation of the bone marrow
that display low mitochondrial activity and express high levels of
HIF1a in a Meis1-dependent manner [39]. Besides a role in
PLOS ONE | www.plosone.org 1 March 2014 | Volume 9 | Issue 3 | e93494
HSCs, both HIF1a and HIF2a also play important role during
hematopoietic development and differentiation, most notably on
erythropoiesis by controlling EPO levels [15].
RGS1 is a member of the R4 subgroup of RGS proteins, known
for their ability to accelerate the hydrolysis of Ga-GTP to Ga-
GDP, thereby dampening the activity of GPCR signaling [5,10].
Little is known about the specificity of the different RGS members
towards different GPCR signaling, but RGS1 has been reported to
be active against SDF1-induced migration of B cells by inhibiting
CXCR4-mediated signaling [30]. Moreover, upregulation of
RGS1 by MEIS1 and binding of MEIS1 to the promoter of
RGS1 could suggest a role of RGS1 in the maintenance of HSCs
[4].
Despite the critical roles of HIF1a and HIF2a in normal
hematopoiesis little is known about the downstream molecular
mechanisms that are involved. Therefore, we set out to identify
specific and overlapping transcriptome changes induced by
hypoxia, HIF1a and HIF2a in human hematopoietic CD34+
stem/progenitor cells. We identified that hypoxia and TGFb
pathways can converge on cell cycle regulation of HSCs by
controlling genes such as CDKN1C/p57. Furthermore, we
identified that RGS1 acts as a TGFb inducible and HIF-
dependent hypoxia target in human CD34+ stem/progenitor cells
that dampens SDF1-induced migration, adhesion and signaling.
Materials and Methods
Cell culture and lentiviral transductions
Neonatal cord blood (CB) was obtained from healthy full-term
pregnancies from the Obstetrics departments of the University
Medical Center and Martini Hospital in Groningen, The Nether-
lands, after informed consent. The protocol was approved by the
Medical Ethical Committee of the UMCG. Donors are informed
about procedures and studies performed with CB by an
information sheet that is read and signed by the donor, in line
with regulations of the Medical Ethical Committee of the UMCG.
CB CD34+ cells were isolated with the use of a hematopoietic
progenitor isolation kit from Miltenyi Biotech according to the
manufacturer’s instructions. OCI-AML3 cells (ACC-582, DSMZ,
Braunschweig, Germany) were cultured in RPMI 1640 (Lonza,
Verviers, Belgium) supplemented with 10% FBS, 1 mmol/L L-
glutamine, and 100 U/mL penicillin/streptomycin (Life Technol-
ogies, Bleiswijk, the Netherlands). UT7/GM cells (ACC-137,
DSMZ, Braunschweig, Germany) were grown in IMDM supple-
mented with 20% FBS, 1 mmol/L L-glutamine, 100 U/mL
penicillin/streptomycin and 10 ng/ml GM-CSF.
Lentiviral vectors expressing constitutively active HIF1a
(P402A,P564A) and HIF2a(P405A,P531A) were constructed by
cloning the HA-tagged HIF cDNA’s, from pCDNA3 vectors
obtained from Addgene (Addgene plasmid numbers 18955 and
18956) into the pRRL-SFFV-iresEGFP vector. A lentiviral vector
expressing a short hairpin against SMAD4 was cloned by
swapping the H1 promoter and hairpin sequence from pRe-
trosuper-SMAD4 (obtained from Addgene, plasmid 15727) into
the pRLVPT vector [46]. pRLVPT-luc was used as the control
(nonspecific) vector. A lentiviral vector expressing myc-tagged
RGS1 was constructed by inserting RGS1 cDNA (obtained by
RT-PCR on CB CD34+ derived RNA and subsequent sequenc-
ing) into the lentiviral expression vector pRRL-IRES-EGFP.
Lentiviral transductions were essentially performed as described
elsewhere [44246]. In short, isolated CD34+ cells were cultured
for 48 hours in serum free medium (HPGM, Lonza, Breda, the
Netherlands) containing 100 ng/ml each of SCF, TPO and FLT-3
ligand. Cells were subsequently transduced with lentiviral particles
in one to two consecutive rounds of 12 hours in the presence of
4 mg/ml polybrene.
Migration assay
Migration assays were performed in transwell plates (6 micron,
Costar). CB-derived CD34+ cells were transduced, sorted and
56104 cells per group were plated in the upper chamber. SDF1
(100 ng/ml) was added to the lower chamber and migration was
allowed for 3 hours. Cells were harvested from the bottom
chamber and counted by FACS using the MACSquant flow
cytometer (Miltenyi Biotec).
mRNA analysis
Total RNA was isolated using the RNeasy kit from Qiagen
(Qiagen, Venlo, The Netherlands) according to the manufacturer’s
recommendations. For real-time RT-PCR, cDNA was prepared
using the iScript cDNA synthesis kit (Bio-Rad, Veenendaal, the
Netherlands) and cycling was performed using SsoAdvanced
SYBR green Supermix (Bio-Rad) in a CFX Connect thermocycler
(Bio-Rad), and quantified using CFX software (Bio-Rad). HPRT
and Ribosomal Protein Like (RPL) 27 expression levels were used
to normalize between samples and to calculate relative expression
levels. Primers and conditions are listed in table S1. Genome-wide
expression analysis was performed on Illumina (Illumina, Inc., San
Diego, CA) BeadChip Arrays Sentrix Human-6 (46k probesets).
Typically, 0.521 mg of RNA combined from three to five
independent transduction experiments was used in labeling
reactions and hybridization with the arrays according to the
manufacturer’s instructions. Data was analyzed using the Bead-
Studio v4 Gene Expression Module (Illumina, Inc.) and Gene-
spring (Agilent, Amstelveen, The Netherlands). The MIAME-
compliant microarray data are available at the Gene Expression
Omnibus, at: http://www.ncbi.nlm.nih.gov/geo/ under accession
number GSE54663.
Flow cytometry analysis
Antibodies CD34 and CD38 were obtained from Beckton
Dickinson (Breda, the Netherlands). For Hoechst and Pyronin Y
staining cells were washed and resuspended in HPGM, stained in
5 mg/ml Hoechst 33342 (Invitrogen) at 37uC for 45 minutes after
which 1.0 mg/ml Pyronin Y (Sigma) was added at 37uC for an
additional 45 minutes. Cells were washed in the solution
containing Hoechst and Pyronin Y, followed by FcR blocking at
4uC for 10 minutes. After staining with CD34-APC and CD38-
Alexa700 at 4uC for 20 minutes, cells were washed and analyzed.
All FACS analyses were performed on an LSRII (Becton
Dickinson) or MACSquant (Milenyi Biotech) flowcytometer and
data was analyzed using WinList 3D (Topsham, USA) or FlowJo
(Tree Star, Oregon, USA) software.
Immunoblotting
Sorted cells were boiled in Laemmli sample buffer for 5 min
prior to separation on 10% SDS-polyacrylamide gels. Proteins
were transferred to PVDF membrane (Millipore, Etten Leur, The
Netherlands) by semidry electroblotting. Membranes were blocked
in Odyssey blocking buffer (Westburg, Leusden, the Netherlands)
prior to incubation with antibodies. Binding of antibodies was
detected by incubating with Alexa680 or IRDye800 labeled
secondary antibodies (Invitrogen, Breda, the Netherlands) and
scanning of the membrane on an Odyssey infrared scanner (Li-
Cor Biosciences, Lincoln, NE, USA). Signal intensities were
quantified using Odyssey 2.1 analysis software and calculated
relative to the highest intensity. Antibody against against
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phosporylated ERK (pT202,pY204) was obtained from Cell
Signaling technologies (Leiden, the Netherlands), antibody against
tyrosine phosphorylated STAT5 was obtained from Becton
Dickinson (Breda, the Netherlands) and antibodies against ERK
(K23) and STAT5 (C17) were obtained from Santa Cruz (Santa
Cruz Biotech, Santa Cruz, CA, USA). Anti myc antibody was
obtained from Roche (Almere, the Netherlands).
Results
Identification of hypoxia, HIF1 and HIF2 target genes in
human CB CD34+ cells
In order to identify HIF1a, HIF2a and hypoxia target genes in
the human hematopoietic stem/progenitor compartment, CD34+
cells were isolated from cord blood and were transduced with
constitutively active HIF1a (P405/P564), HIF2a (P405/531) or
control vectors and RNA was isolated from GFP+-sorted cells 24
hrs after the last transduction round (Figure 1A). Overexpression
of HIF1a and HIF2a was confirmed at the RNA level (Figure 1B).
Simultaneously, CB CD34+ cells were cultured under normoxia
(21% O2) or hypoxia (1% O2) for 24 hrs followed by RNA
isolation (Figure 1A). RNA from 5 separate experiments were
pooled and transcriptomes were analyzed using Illumina BeadAr-
rays. All data is summarized in Table S2. We initially focused on
the HIF and hypoxia upregulated genes and significant gene
expression changes in all groups are shown in the VENN diagram
in Figure 1C. Thus, 84 genes could be identified that were
upregulated by HIF1a, HIF2a as well as hypoxia. Furthermore,
we observed a strong overlap in HIF1a and HIF2a target genes
(553), although HIF1a-specific (281), HIF2a-specific (736) and
hypoxia-specific (446) target genes could be identified as well.
Clustering analyses were performed on these common and specific
gene signatures and a number of examples of genes within these
lists are indicated in Figure 1D. Q-RT-PCRs were performed to
validate gene array data. A good overlap between results was
obtained and some examples are shown in Figure 1E. IL8 was
confirmed to be a common gene hypoxia and HIF1/2 target,
HMOX1 was upregulated by hypoxia but not HIF1 or HIF2,
MT3 was specifically upregulated by HIF1, and WNT1 and
WNT10B were specifically upregulated by HIF2. Gene ontology
(GO) analysis was performed on genes upregulated by hypoxia,
HIF1 or HIF2, and all significant GO terms with an FDR,1 are
shown in Figure 1F. Besides expected GO terms such as ‘‘response
to hypoxia’’, ‘‘response to oxygen levels’’, and ‘‘angiogenesis’’ in
hypoxia or HIF1 upregulated genes, we observed that particularly
HIF2-upregulated genes were enriched for processes associated
with ‘‘apoptosis’’ and ‘‘programmed cell death’’.
Next, we performed Gene set Enrichment Analysis (GSEA) on
the complete HIF1, HIF2 and hypoxia transcriptomes, which
revealed that Gene Ontology terms such as ‘‘hypoxia’’, ‘‘glycol-
ysis’’, ‘‘angiogenesis’’ and ‘‘gluconeogenesis’’ were significantly
enriched in all groups, as anticipated (Figure 2A). Somewhat more
surprisingly, these analyses also revealed significant enrichment for
processes associated with cellular transformation, such as ‘‘H-Ras
oncogenic signature’’, ‘‘SOX4 targets’’ and several terms associ-
ated with leukemic transformation (Figures 2A, B). Finally, we also
observed significant enrichment for terms associated with TGFb
signaling. This was independently confirmed using a published
dataset in which TGFb target genes were identified in CB CD34+
cells [35]. Significant enrichment for the top TGFb-upregulated
genes was observed with our hypoxia (Figure 2C) and HIF1/2
(data not shown) transcriptomes.
Since we identified glycolysis was one of the processes that were
enriched in our HIF and hypoxia transcriptomes we focused on
expression of the glucose transporters SLC2A1 (GLUT1) and
SLC2A3 (GLUT3). We compared the upregulation of these genes
in our gene array study (Figure 1C) with data obtained from
independent Q-PCR analyses (Figure 2D, additional Figure S1 in
File S1) and observed a good correlation between both datasets,
where by SLC2A1 and SLC2A3 were upregulated by hypoxia,
HIF1a, as well as by HIF2a.
Hypoxia sensitizes cells for TGFb signaling
Since we observed a striking cooperation between TGFb and
hypoxia in activating similar target genes we decided to investigate
this cooperation in further detail, in particular in relation to the
cell cycle status of human hematopoietic stem/progenitor cells.
We observed that the cell cycle inhibitor CDKN1C/p57 was
upregulated by hypoxia, in particular when cells were co-
stimulated with TGFb (Figure 3A, Figure S2 in File S1). These
effects were not observed, or at least much less pronounced on the
expression of other cell cycle inhibitors such as CKN1A/p21 or
CDKN1B/p27 (Figure 3A, Figure S2 in File S1). These
observations could be further substantiated in studies in which
we analyzed the cell cycle status and quiescence of CD34+/
CD382 stem cells and CD34+/CD38+ progenitor cells using
Hoechst 33258 and Pyronin Y. Stimulation with TGFb resulted in
an increase in cells in G1 and a decrease in cells in G2/M, both in
the stem compartment as well as in more committed progenitor
cells (Figure 3B). Similarly, cells cultured under hypoxic conditions
displayed a decrease in cells in G2/M, while an increase in
quiescent cells (G0) was observed. This percentage of quiescent
cells was even further increased when hypoxic cells were
stimulated with TGFb (Figure 3B).
Since cells appeared to be more responsive to TGFb under
hypoxic conditions we investigated whether this increased
responsiveness might be explained by higher levels of TGFb
receptor expression. Quantitative RT-PCR analysis in a hypoxia
and TGFb responsive cell line (OCI-AML3) revealed that indeed
both TGFBR1 as well as TGFBR2 were upregulated by hypoxia
(Figure 4A, Figure S3A in File S1). In line with these observations,
we noted that the well described TGFb target genes such as
SMAD6 and SMAD7 were also expressed at significantly higher
levels in response to TGFb when cells were grown under hypoxic
conditions (Figure 4A, Figure S3A in File S1). These observations
could be extended to hypoxia-responsive genes that had previously
not been identified as classical TGFb target genes. For instance,
the Ga-coupled receptor GTPase RGS1 which we identified as
one of the top genes induced by hypoxia (Figure 1D and Table S2)
was even strongly further enhanced when hypoxic cells were
stimulated with TGFb (Figure 4B, Figure S3B in File S1). The
same was true for the RGS R4 family member RGS16 (Figure 4B,
Figure S3B in File S1). Experiments performed in cordblood
CD34+ cells showed a similar upregulation of RGS1 and RGS16
(Figure S3D in File S1). Thus, these data strongly suggested that
hypoxic conditions sensitize human stem/progenitor cells for
TGFb. To further confirm these observations, kinetics and TGFb
dosage studies were performed. CB CD34+ cells were cultured
under normoxic or hypoxic conditions after which cells were
stimulated with TGFb for 30, 60 or 120 min. As shown in Figure
4C (and Figure S3C in File S1), exposure of cells to TGFb for only
30 min already resulted in a strong upregulation of SMAD7,
which was most prominent in cells cultured under hypoxia.
Similar observations were done for CDKN1C/p57, where even at
the lowest TGFb concentrations tested, a strong upregulation of
CDKN1C/p57 could be observed in cells grown under hypoxic
conditions (Figure 4D).
Convergence of Hypoxia and TGFb Pathways
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Figure 1. Identification of hypoxia, HIF1 and HIF2 target genes in human CB CD34+ cells. A. Schematic representation of performed
experiments. B. Q-RT-PCR to verify HIF1/2 expression in the mRNA preparations used for transcriptome analysis. C. VENN diagram displays genes
upregulated by HIF1, HIF2 or hypoxia. Supervised cluster analysis is shown, including a number of selected upregulated genes and associated GO
terms. D. CB CD34+ cells were transduced with the indicated overexpression vectors at normoxia and/or cultured under hypoxic conditions for
24 hours. Q-RT-PCR was performed for the indicated targets. (e.v. = empty vector, n.d. = not detectable). E. Gene ontology analysis on genes
upregulated by hypoxia, HIF1 or HIF2. All GO terms with an FDR,1 are shown.
doi:10.1371/journal.pone.0093494.g001
Convergence of Hypoxia and TGFb Pathways
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CB CD34+ cells are known to express and secrete relatively high
levels of latent TGFb which still needs to be processed in order to
become activated [3]. Recently, it was demonstrated that GFAP-
expressing glial cells within the bone marrow are able to process
latent TGFb into its active form [47]. We questioned whether
hypoxia itself, possibly via secretion and/or activation of certain
proteases, might also be sufficient to activate latent TGFb
produced by human CD34+ cells. To address this hypothesis we
undertook a series of experiments. First, we verified that human
CB CD34+ cells indeed secrete latent TGFb that can be activated
for instance by heat treatment. Medium was harvested from
cultured CB CD34+ cells both under normoxic as well as hypoxic
conditions, was heat treated at 80uC and then used to stimulate
human CB CD34+ cells. As shown in Figure 4E, this heat-treated
medium was equally capable of inducing SMAD7 or CDKN1C/
p57 expression as compared to treatment with TGFb. Further-
more, this induction of SMAD7 and CDKN1C/p57 could be
inhibited by either treatment with antagonizing anti-TGBb
antibodies or by downmodulation of SMAD4 using lentiviral
shRNA vectors (data not shown), indicating the specificity of the
responses induced by the heat-treated conditioned medium.
Conditioned medium that was harvested from cells grown under
hypoxic conditions was not able to induce the TGFb target genes
CDKN1c/p57 (Figure 4F) and SMAD7 (not shown), and no
differences were observed when different amounts of heat-treated
conditioned medium was used from cells frown under normoxic or
hypoxic conditions. These data strongly suggest that hypoxia itself
is not sufficient to activate latent TGFb.
TGFb, but not hypoxia, induced cell cycle arrest is SMAD
dependent
Subsequently we investigated whether hypoxia-induced expres-
sion of target genes and cell cycle arrest would be SMAD-signaling
dependent. Using OCI-AML3 cells, SMAD4 was downregulated
Figure 2. GO and GSEA analysis on hypoxia, HIF1 and HIF2 target genes. A. GSEA terms that are enriched in HIF1, HIF2 and hypoxia
transcriptomes. B. Examples of enriched GSEA terms for the HIF1 transcriptomes are shown. C. GSEA with hypoxia transcriptome and a .2fold TGFb
upregulated dataset in CB CD34+ cells. D. CB CD34+ cells were transduced with the indicated overexpression vectors at normoxia and/or cultured
under hypoxic conditions for 24 hours. Q-RT-PCR was performed for SLC2A1 and SLC2A3. (e.v. = empty vector).
doi:10.1371/journal.pone.0093494.g002
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using shRNA lentiviral vectors, which efficiently inhibited TGFb
induced expression of SMAD7 or RGS1, both under normoxic as
well as hypoxic conditions (Figure 5A). However, hypoxia-induced
expression of SMAD7 and RGS1 did not depend on SMAD4
(Figure 5A). Similarly, we observed that TGFb-induced cell cycle
arrest in CB CD34+ cells, but not hypoxia-induced cell cycle
arrest, depended on SMAD4 (Figure 5B). These data indicate that
TGFb and hypoxia pathways do not act synergistically but rather
operate side by side to activate similar target genes. Indeed, we
observed that CDKN1C/P57, RGS1 and RGS16 promoters all
contain potential binding sites for SMAD complexes (SBEs) as well
as HIF transcription factors (HREs) (Figure 5C).
RGS1 dampens SDF1 induced migration, adhesion and
signaling in CB CD34+ cells
RGS1 is a member of the R4 subgroup of RGS proteins, known
for their ability to accelerate the hydrolysis of Ga-GTP to Ga-
GDP, thereby dampening the activity of GPCR signaling [10]. To
test the hypothesis that RGS1, induced by hypoxia and/or TGFb,
could influence the strength of specific signaling cascades, cells
were lentivirally transduced with myc-tagged RGS1 and the
response to SDF-1 stimulation was determined by migration assays
as well as Western blots. RGS1 overexpression clearly resulted in a
strongly (approximately 50%) reduced migration of CB CD34+
cells towards 100 ng/ml SDF1 (Figure 6A). The ERK/MAPK
Figure 3. p57 and HSC quiescence are induced by both TGFb and hypoxia. A. CB CD34+ cells were cultured under normoxic and hypoxic
conditions for 24 hours and stimulated for different times with 1 ng/ml TGFb where after Q-RT-PCR was performed for CDKN1A/p21, CDKN1B/p27
and CDKN1C/p57. A representative experiment out of 2 independent experiments is shown, error bars indicate standard deviation of PCR performed
in triplicate. B. CB CD34+ cells were treated as indicated in the scheme and cell cycle analysis was performed using Hoechst and PyroninY staining.
Representative FACS plots and the cell cycle distribution in CD34+/CD382 and CD34+/CD38+ fractions are shown.
doi:10.1371/journal.pone.0093494.g003
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pathway is one of the signaling cascades that can be induced by
SDF-1, and overexpression of RGS1 resulted in a significant
reduction in SDF-1-induced ERK phosphorylation in CB CD34+
cells (Figure 6B). In line with these results, stimulation of OCI-
AML3 cells with SDF1 but also with GM-CSF or TPO revealed
that ERK phosphorylation is dampened by overexpression of
RGS1 (Figure 6C, Figure S4 in File S1). In contrast, GM-CSF-
induced STAT5 phosphorylation was not affected by RGS1
overexpression (Figure 6C, Figure S4 in File S1). Culturing OCI-
AML3 cells or UT7-GM cells under hypoxic conditions for
24 hours before stimulation with SDF1 revealed that also under
these conditions ERK phosphorylation was reduced, suggesting an
important role for RGS1 in controlling cytokine signaling under
hypoxic conditions (Figure 6D and E).
Discussion
Despite a high degree of sequence homology between HIF1 and
HIF2, specific functions have been described for each [38].
HIF12/2 embryos suffer from severe cardiac and vascular
Figure 4. Hypoxia sensitizes cells for TGFb signaling and CB CD34+ express latent TGFb. A. OCI-AML3 cells were cultured for 24 hours
under normoxic and hypoxic conditions, treated with TGFb (1 ng/ml) for 3 hours and Q-RT-PCR was performed. B. OCI-AML3 cells were treated as in
A, Q-RT-PCR was performed for RGS1 and RGS16. C. Q-RT-PCR analysis on CB CD34+ cells which were cultured under normoxic and hypoxic
conditions and treated with 1 ng/ml TGFb for different timepoints. D. CB CD34+ cells were treated as in C, but with different concentrations of TGFb.
E. CB CD34+ cells were cultured for 24 hours under hypoxic and normoxic conditions. Supernatant of normoxic cells was harvested and split in two,
where one half was treated by incubation at 80 degrees for 10 minutes. These supernatants were added to normoxic cells for 3 hours (sup and sup +
heat), along with fresh medium and fresh medium containing 1 ng/ml TGFb. Q-RT-PCR was performed for SMAD7 and CDKN1C. F. Supernatant was
harvested from hypoxic and normoxic cultured CB CD34+ cells, heat treated as in E and added back in different amounts. Heat-treated fresh medium
and TGFb containing medium was added as controls. Representative experiments out of 223 independent experiments is shown, error bars indicate
standard deviation of PCR performed in triplicate.
doi:10.1371/journal.pone.0093494.g004
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malformations and die by E10.5 [23]. HIF22/2 mice also display
vascular defects and die by E12.5 [32] or a couple of months after
birth due to ROS-mediated multiorgan failure and metabolic
abnormalities [37], depending on the genetic background of the
mouse strain used. Conditional knockout models have revealed
that HIF1 is required to maintain HSC quiescence and loss of
HIF1 impairs stem cell function when exposed to stress such as
serial transplantation, myelo-suppression or upon aging [42]. In
contrast, constitutive or inducible loss of HIF2 did not affect steady
state hematopoiesis, HSC numbers or serial repopulating capacity
of HSCs [14], although a recent paper in human CB CD34+ cells
indicated that knockdown of HIF2a did impede long-term
repopulating activity [33]. Our data indicate that within human
hematopoietic CD34+ stem/progenitor cells HIF1 and HIF2
induce overlapping but also distinct gene expression patterns.
Glucose metabolism genes such as HK2, SLC2A1 and SLC2A3
can be activated by both HIF1 and HIF2, and the same is true for
IL8, CXCR4 and CDKN1C. The zinc-binding protein Metallo-
thionein 3 (MT3) is very specifically upregulated by HIF1 in
human CD34+ cells, although little is known about its role in
hematopoiesis. HIF2-specific target genes include WNT1 and
WNT10B. Gene ontology analysis revealed that a subset of genes
associated with apoptosis is also preferentially controlled by HIF2.
It is important to realize that changes in RNA expression might
not always directly reflect changes at the protein level, particularly
under low oxygen conditions [12]. Nevertheless, our data do
clearly indicate that besides common HIF regulated genes, HIF1
and HIF2 specific genes exist as well. These data are in line with
recent ChIP-seq experiments in MCF-7 breast cancer cells in
which genome-wide HIF1 and HIF2 binding sites were mapped
[36]. We find a good overlap with glucose metabolism and
oxidative stress related genes when comparing their datasets with
ours although differences exist as well, and for instance no direct
binding was observed on IL8, CXCR4 or MT3 loci by Scho¨del
Figure 5. TGFb, but not hypoxia, induced cell cycle arrest is SMAD4 dependent. A. CB CD34+ cells were transduced with vectors expressing
short hairpins against SMAD4 and luciferase, sorted and cultured for 24 hours under normoxic and hypoxic conditions. Cells were then stimulated for
3 hours with 1 ng/ml TGFb and Q-RT-PCR was performed for SMAD7 and RGS1. A representative experiment out of 3 independent experiments is
shown, error bars indicate standard deviation of PCR performed in triplicate. B. CB CD34+ cells were transduced as in A but now cultured for 24 hours
under normoxia (left panel) and normoxia versus hypoxia (right panel) and subsequently treated with TGFb for 24 hours. Cell cycle distribution was
measured using Hoechst staining. C. Schematic representation of the 2,5 kb upstream promoter region of RGS1, RGS16 and CDKN1C.
doi:10.1371/journal.pone.0093494.g005
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et al [36]. Thus, these targets might indirectly be controlled by
HIF1 or 2, or it is also plausible that differences in HIF targets
between cell types might exist.
We have also been able to identify genes that are upregulated by
hypoxia, but not by HIF1 or HIF2. These include for instance
ARHGAP28, KLF2, EGR1 and HMOX1. HMOX1 expression
has been shown to be regulated by Nuclear factor erythroid 2-
Related factor 2 (NRF2) [1]. NRF2 is a global regulator of the
oxidative stress response, but has recently also been shown to
regulate several aspects of hematopoietic stem cell homeostasis
[43]. Upon exposure to oxidative stress NRF2 is released from its
negative regulator KEAP and thereby escapes from degradation,
allowing nuclear translocation and activation of target genes [22].
A recent study indicated that hypoxia-induced HMOX1 expres-
Figure 6. RGS1 dampens SDF1-induced migration and signaling. A. Transwell migration assay towards SDF1 (100 ng/ml) using CB CD34+
cells transduced with empty vectors or RGS1. The mean and standard deviation of three independent experiments is shown. B. Western blot of
CD34+ cells transduced with empty vectors or RGS1 that were stimulated with SDF1 (20 ng/ml) for different timepoints. C. Western blot of OCI-AML3
cells transduced with empty vectors or RGS1 that were stimulated with different cytokines (20 ng/ml each) for 10 minutes. D. OCI-AML3 cells were
cultured for 24 hours under normoxia or hypoxia, stimulated with 20 ng/ml SDF1 for 10 minutes and Western blotted for phosphorylated ERK1/2. E.
UT7-GM cells were cultured for 24 hours under normoxia or hypoxia, stimulated with 20 ng/ml SDF1 for different timepoints and Western blotted for
phosphorylated ERK1/2. Band intensities for phospho-ERK1/2 were measured and plotted as relative signal (in B-E). Representative experiments out
of 2-3 independent experiments are shown.
doi:10.1371/journal.pone.0093494.g006
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sion is repressed upon downmodulation of NRF2 [25], strongly
suggesting that this pathway, but not the HIF pathway, controls
HMOX1 expression under hypoxic conditions. The transcription
factor EGR1 is highly expressed in the most primitive hemato-
poietic stem cell compartment where it critically regulates self-
renewal as well the localization of HSCs within the bone marrow
niche [29]. Loss of one allele of HMOX1 is sufficient to impair
radioprotection and serial repopulation of HSCs [7]. Together,
these results indicate that, besides the HIF pathway, other
hypoxia-sensitive signaling routes including the NRF2 pathway
fulfill essential roles in HSCs within the hypoxic bone marrow
niche.
Besides hypoxia and glucose metabolism signatures, gene set
enrichment analysis revealed a remarkable overlap of HIF/
hypoxia targets with genes controlled by TGFb. A key example of
one such gene is the cell cycle inhibitor p57/CDKN1C. While the
expression of other cell cycle regulators such as p21/CDKN1A or
p27/CDKN1B was hardly affected by either hypoxia or TGFb
treatment, the expression of p57/CDKN1C was strongly induced
by TGFb in a dose-dependent manner, in particular under
hypoxic conditions. In part this may be explained by an increase in
TGFBR1 and TGFBR2 expression in upon hypoxia. These data
suggest that cells cultured under hypoxic conditions become
hypersensitive to TGFb, a feature that was also observed for other
genes such as RGS1 and RGS16 that were most strongly
upregulated by TGFb under hypoxia. These data are of particular
interest since it was demonstrated that TGFb induces HSC
hibernation [48]. We also confirmed that TGFb can induce a cell
cycle arrest and increases quiescence of HSCs and MPPs, in
particular under hypoxic conditions. In vivo this might be
mediated by non-myelinating Schwann cells within the bone
marrow niche that provides factors that can activate latent TGFb
which was essential for HSC maintenance [47]. Deletion of
SMAD4, a critical downstream mediator of canonical TGFb
signaling impaired HSC self-renewal and repopulation capacity
[19]. Clearly, TGFb signaling is a critical mediator of hemato-
poietic stem cell fate, in part by controlling the expression of p57/
CDKN1C [35] and it is intriguing that HSCs are particularly
sensitive to TGFb stimulation under hypoxic conditions which are
present in the bone marrow niche.
Human CD34+ cells themselves express high levels of latent
TGFb, and we hypothesized that this might be activated by
hypoxia itself? possibly by inducing the activation and/or secretion
of certain proteases within CD34+ cells. However, we have not
found evidence for this hypothesis, and it appears more likely that
other niche components, such as for instance non-myelinating
Schwann cells, are required to activate TGFb within the hypoxic
bone marrow microenvironment.
RGS1 was identified as a common gene that is upregulated by
hypoxia, HIF1 and HIF2. Although little is known about its role in
hematopoietic stem/progenitor cells, it has been shown that RGS1
can reduce migration of B cells towards SDF1 [16] and can be
upregulated by IFNb-1b in monocytes, T cells and B cells. RGS
proteins interfere with G-protein signaling by accelerating the
hydrolysis of Ga-GTP to Ga-GDP, thereby dampening the
activity of GPCR signaling [10]. Indeed, we observed that
migration of human CB CD34+ cells towards SDF1 was impaired
by RGS1 overexpression or when cells were grown under hypoxia,
coinciding with a reduced phosphorylation of ERK. Besides SDF1
signaling, activation of the MAPK/ERK pathway by GM-CSF or
TPO was also impaired by RGS1 overexpression, while GM-CSF-
induced activation of STAT5 was unaltered. These data suggest
that RGS1 exerts its effects on a G-protein coupled receptor
upstream of the MAPK/ERK pathway, thereby possibly affecting
RAS activity. Our data indicate that when cells encounter hypoxic
conditions they respond differently to cytokines and growth factors
and it will be interesting to further elucidate the underlying
mechanisms and consequences thereof for the fate of hematopoi-
etic stem and progenitor cells.
Conclusion
In conclusion, our work reveals common hypoxia-HIF1-HIF2
gene signatures in human CD34+ stem/progenitor cells, but we
also identified specific target genes that are exclusively regulated
by HIF1, HIF2 or hypoxia. A strong overlap between these
common gene signatures and TGFb-regulated genes exists and a
key example of one such gene is the cell cycle regulator p57/
CDKN1C. Combined hypoxia treatment or HIF overexpression
together with TGFb stimulation resulted in enhanced expression
of CDKN1C and enhanced cell cycle arrest within the CD34+/
CD382 stem cell compartment. Finally, the Ga-coupled receptor
GTPase RGS1 was identified as a HIF-dependent hypoxia target
that dampens SDF1-induced migration and signaling in human
CD34+ stem/progenitor cells.
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